Page 22 - U11248 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from U11248. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In U11248 Today - Breaking & Trending Today

Amenorrhea Is Common After Chemotherapy for Breast Cancer

More than half of women treated with chemotherapy for localized breast cancer reported persistent amenorrhea at year 4 after diagnosis, according to a French study. ....

France General , Rayan Kabirian , Gustave Roussy Institute In Villejuif , Gustave Roussy Institute , Breast Cancer , Alignant Breast Neoplasm , Alignant Neoplasia , Endocrine Therapy , Hormone Therapy , Dry Mouth , Her2 Positive Breast Cancer , Her2 Breast Cancer , Adverse Effects , Side Effects , Antineoplastic Drug , Nti Cancer Agents ,

Cost Paramount When Choosing Metastatic Breast Cancer Treatment

Differences in outcomes and quality of life across commonly used treatments for endocrine-refractory and triple-negative metastatic breast cancer were "razor-thin," leaving cost as a key factor. ....

North Carolina , United States , University Of North Carolina , Scottd Ramsey , Stephanieb Wheeler , Katherinee Reeder Hayes , Gillings School Of Global Public Health , School Of Medicine , Fred Hutchinson Cancer Research Center , Gillings School , Global Public Health , Clinical Oncology , Metastatic Breast Carcinoma , Alignant Neoplasia , Antineoplastic Drug , Nti Cancer Agents , Breast Cancer , Alignant Breast Neoplasm , Quality Of Life , Ealth Related Quality Of Life , Triple Negative Breast C ,

Time to Stop Approving Drugs From Single-Arm Trials?

"Single-arm trials are not meant to provide confirmatory evidence sufficient for approval," according to one expert. ....

Israel General , United States , France General , Nathani Cherny , Bishal Gyawali , Bristol Myers Squibb , European Society For Medical Oncology Congress , American Society Of Clinical Oncology , Queen University , Vivio Health , Drug Administration , European Organization For The Research , Shaare Zedek Medical Center , European Society , Medical Oncology , Second Thought , European Organization , American Society , Healthcare And Medical Technology , Ealth And Medical Tech , Ealth And Med Tech , Ealth And Medical Technology , Clinical Research , Clinical Trials , Linical Studies , Antineoplastic Drug ,

Will Major New FDA Law Include Accelerated Approvals Process?

Advocates who have been calling for reforms in the accelerated approvals process are concerned that Congress may avoid this issue while finalizing a major FDA law. ....

United States , Mikkael Sekeres , Michaela Carome , Eli Lilly , Frank Pallone Jr , Reshma Ramachandran , Health Research Group , Commerce Committee , Drug Administration , House Energy , Oncologic Drugs Advisory Committee , Public Trust , Senate Health , Prescription Drug User Fee Act , Richard Burr , Medscape Medical , Commerce Chairman Frank Pallone , Pensions Chairwoman Patty Murray , Endpoints News , Us Food And Drug Administration , Nited States Food And Drug Administration , Alignant Neoplasia , Angiogenesis Inhibitor , Nhibitor Angiogenesis , Antineoplastic Drug , Nti Cancer Agents ,

Where Does Ripretinib Fit Into Treatment for GIST?

The relative newcomer to the field, ripretinib, was compared to standard second-line treatment with sunitinib in patients with advanced gastrointestinal stromal tumors. ....

New York , United States , Columbia University , West German , Sebastian Bauer , Gary Schwartz , Daiichi Sankyo , Nanobiotix Incyte , Drug Administration , Boehringer Ingelheim , Deciphera Pharmaceuticals , German Cancer Centre , Clinical Oncology , West German Cancer Centre , Blueprint Medicines , Adcendo Aps , Gastrointestinal Stromal Tumor , Umor Gastrointestinal Stromal , Antineoplastic Drug , Nti Cancer Agents , Biologic Therapy , Antibody Drug Conjugates Adcs , Clinical Research , Clinical Trials , Linical Studies , Healthcare And Medical Technology ,